Damanhour University Researchers Highlight Research in Lymphoma [Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen...].

A recent report from Damanhour University discusses research on lymphoma treatment. The study compared two conditioning regimens, BeEAM and CEM, for autologous stem cell transplantation (ASCT) in lymphoma patients. The findings showed that the CEM regimen had advantages over the BeEAM regimen, including faster recovery of neutrophils and platelets, shorter hospitalization duration, and improved overall and progression-free survival rates. The study suggests that the CEM regimen may be superior, but further research with larger sample sizes is needed. The research was conducted at the International Medical Center in Cairo, Egypt, and funded by Damanhour University. [Extracted from the article]